TL;DR •UC Berkeley has launched the first-ever neuroimaging study focused specifically on how psilocybin affects the healthy aging brain. •Researchers believe psilocybin may boost neuroplasticity, potentially counteracting the structural brain changes and cognitive decline associated with aging. •While most psychedelic studies focus on younger people...
TL;DR •A major 2022 survey revealed significant differences between what psychedelic users want researched and what academic institutions prioritize. •While institutions focus heavily on medicalizing psychedelics for clinical trials, the community prioritizes best practices for non-clinical use and broader societal impacts. •Users expressed a strong...
TL;DR •A new systematic review of 25 studies found that psilocybin-assisted therapy (PAP) significantly reduces anxiety symptoms across various mental health conditions. •The treatment produced a large reduction in anxiety for patients who received it, showing promise as a potential alternative to traditional medications. •While...
TL;DR •A 2026 randomized clinical trial found that psilocybin with psychotherapy was linked to more cocaine-abstinent days than an active placebo with psychotherapy. •The trial included 40 adults with cocaine use disorder and used a single oral psilocybin dose plus manualized psychotherapy. •Participants who received...